Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation.

Human pathology - 1 Sept 2005

van der Aa Madelon N M, van Leenders Geert J L H, Steyerberg Ewout W, van Rhijn Bas W, Jöbsis Adriaan C, Zwarthoff Ellen C, van der Kwast Theodorus H

Abstract excerpt

Superficially invasive (pT1) papillary urothelial cell carcinomas (UCCs) may run a variable course. Several attempts have been made for the substaging of UCC to identify the clinically aggressive tumors. We present a new substaging system, based on the extent of invasion. From a series of 53 primary pT1 UCC, 24 cases showed invasion of the subepithelial stroma by an invasive front extending more than a maximum...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to Neoplasm Invasiveness

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Staging

Share to Prognosis

Share to Protein-Tyrosine Kinases

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Receptors, Fibroblast Growth Factor

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 16153461
DOI: 10.1016/j.humpath.2005.06.017

Genes

FGFR3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation.PMID 16153461Read ↗

The FGFR3 mutation is related to favorable pT1 bladder cancer.Semantic proximity Read ↗

Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation statusSemantic proximity Read ↗

Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.Semantic proximity Read ↗

FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer.Semantic proximity Read ↗

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.Semantic proximity Read ↗

FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder.Semantic proximity Read ↗

Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.Semantic proximity Read ↗

Diagnostic and Prognostic Implications of FGFR3high/Ki67high Papillary Bladder Cancers.Semantic proximity Read ↗

Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas.Semantic proximity Read ↗

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma.Semantic proximity Read ↗

The Utility of GATA3 in the Diagnosis of Urothelial Carcinomas With Variant Morphologic Patterns.Semantic proximity Read ↗

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.